CF NEWS
AND RESEARCH
CF Bites press coverage, national CF research news, and stories from our team - all in one place.
Press Coverage
CF Bites in the News
How Charleston and South Carolina media have covered the CF Bites story.
Research Pipeline
The CFF has helped fund more than 50% of all CF therapies. Trikafta now reaches over 90% of CF patients.
CFTR Modulators
Trikafta targets the root cause of CF rather than just symptoms. The next goal is reaching the 10% it cannot yet help.
Gene Therapy
Researchers are working on a treatment that works for every CF mutation type. That would be the closest thing to a universal cure.
National
CF Research News
From the Cystic Fibrosis Foundation. Click to read here without leaving the page.
CF By the Numbers
Key facts for patients, donors, and advocates
Americans currently living with cystic fibrosis
New CF diagnoses each year in the United States
CF patients now eligible for CFTR modulator therapy
Approximate annual cost of Trikafta per patient
Projected median survival for those born today with CF
CF therapies brought to market with CFF funding
Reduction in hospitalizations with Trikafta treatment
Invested by the CFF in research and drug development
Sources: Cystic Fibrosis Foundation Patient Registry 2024 and CFF.org
Stay in the Loop
CF research moves fast. Get updates and CF Bites event news in your inbox.